Defense Against Biological Attacks,, Sunit K. Singh,Jens H. Kuhn, Editör, Springer Nature, Basel, ss.139-159, 2019
Brucellosis is an ancient disease, the etiologic agent being bacteria of the Brucella
genus. While the disease has a global distribution in humans and animals, the
majority of cases are reported in Mediterranean, Middle East, Central Asia, Africa,
Central America, and Latin America [1 , 2 ]. Due to the potential for misuse of these
organisms, Brucella spp. are categorized as group B priority agents by both the
Centers for Disease Control and Prevention (CDC) and National Institute of Allergy
and Infectious Disease (NIAID) in the USA. The agent is also included on the lists of
potential biological agents of weapons by the World Health Organization (WHO),
the Biological and Toxin Weapons Convention (BTWC), and the North Atlantic
Treaty Organization (NATO) [3–5 ].